Myriad Genetics, Inc. earnings per share and revenue

MYGN earnings per share for the last quarter are 0.06 USD whereas the estimation was 0.02 USD which accounts for 220.15% surprise. Company revenue for the same period amounts to 213.30 M USD despite the estimated figure of 210.76 M USD. Estimated earnings per share for the next quarter are 0.03 USD, and revenue is expected to reach 214.95 M USD. Also watch annual changes over time to get a bigger picture of MYGN earnings per share and revenue dynamics.